McKesson Corporation (NYSE:MCK) received a $179.00 target price from Needham & Company LLC in a research report issued to clients and investors on Monday, October 16th. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price target points to a potential upside of 24.70% from the company’s previous close.
Several other equities analysts have also recently commented on MCK. UBS AG reaffirmed a “neutral” rating and set a $166.00 price target (up previously from $156.00) on shares of McKesson Corporation in a research report on Monday, June 26th. BidaskClub cut shares of McKesson Corporation from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Jefferies Group LLC upgraded shares of McKesson Corporation from a “hold” rating to a “buy” rating and set a $153.00 price target on the stock in a research note on Thursday, July 27th. Vetr lowered shares of McKesson Corporation from a “strong-buy” rating to a “buy” rating and set a $187.51 price target on the stock. in a research note on Monday, July 17th. Finally, Zacks Investment Research upgraded shares of McKesson Corporation from a “hold” rating to a “buy” rating and set a $184.00 price target on the stock in a research note on Wednesday, July 12th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and ten have issued a buy rating to the company. McKesson Corporation presently has a consensus rating of “Hold” and a consensus target price of $172.40.
McKesson Corporation (MCK) opened at 143.54 on Monday. The stock has a market cap of $30.18 billion, a PE ratio of 6.51 and a beta of 1.17. The company’s 50-day moving average price is $151.90 and its 200-day moving average price is $153.68. McKesson Corporation has a 12-month low of $114.53 and a 12-month high of $169.29.
McKesson Corporation (NYSE:MCK) last issued its quarterly earnings results on Thursday, October 26th. The company reported $3.28 EPS for the quarter, topping the consensus estimate of $2.80 by $0.48. McKesson Corporation had a net margin of 2.42% and a return on equity of 25.76%. The business had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.69 billion. During the same quarter last year, the company posted $2.94 earnings per share. The company’s quarterly revenue was up 4.2% compared to the same quarter last year. On average, equities analysts expect that McKesson Corporation will post $12.05 EPS for the current fiscal year.
WARNING: This piece was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2017/10/27/mckesson-corporation-mck-given-a-179-00-price-target-by-needham-company-llc-analysts.html.
In other McKesson Corporation news, SVP Erin M. Lampert sold 900 shares of McKesson Corporation stock in a transaction on Thursday, September 7th. The shares were sold at an average price of $155.65, for a total transaction of $140,085.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Marie L/Ca Knowles sold 1,083 shares of McKesson Corporation stock in a transaction on Monday, July 31st. The shares were sold at an average price of $162.55, for a total transaction of $176,041.65. The disclosure for this sale can be found here. Insiders sold a total of 952,066 shares of company stock valued at $145,736,987 in the last ninety days. Company insiders own 1.20% of the company’s stock.
Several large investors have recently modified their holdings of the business. Family Firm Inc. boosted its stake in shares of McKesson Corporation by 0.3% during the 2nd quarter. Family Firm Inc. now owns 1,922 shares of the company’s stock valued at $316,000 after buying an additional 5 shares during the period. Cypress Capital Group raised its holdings in shares of McKesson Corporation by 0.3% during the 2nd quarter. Cypress Capital Group now owns 3,588 shares of the company’s stock valued at $590,000 after purchasing an additional 10 shares in the last quarter. Tompkins Financial Corp raised its holdings in shares of McKesson Corporation by 2.3% during the 2nd quarter. Tompkins Financial Corp now owns 785 shares of the company’s stock valued at $129,000 after purchasing an additional 18 shares in the last quarter. First Financial Bank Trust Division raised its holdings in shares of McKesson Corporation by 1.3% during the 2nd quarter. First Financial Bank Trust Division now owns 1,811 shares of the company’s stock valued at $298,000 after purchasing an additional 23 shares in the last quarter. Finally, SOL Capital Management CO raised its holdings in shares of McKesson Corporation by 0.9% during the 2nd quarter. SOL Capital Management CO now owns 3,556 shares of the company’s stock valued at $585,000 after purchasing an additional 30 shares in the last quarter. 85.29% of the stock is owned by institutional investors.
McKesson Corporation Company Profile
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.
Receive News & Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related companies with MarketBeat.com's FREE daily email newsletter.